Elon Musk’s Neuralink taps FDA regulator who led division overseeing the startup

Home News Elon Musk’s Neuralink taps FDA regulator who led division overseeing the startup
Spread the love

<p>Elon Musk’s Neuralink has appointed David McMullen, a former US health regulator, to lead its medical affairs. McMullen previously oversaw devices like Neuralink’s brain implants at the FDA.</p><p>“><figcaption class=Elon Musk’s Neuralink has appointed David McMullen, a former US health regulator, to lead its medical affairs. McMullen previously oversaw devices like Neuralink’s brain implants at the FDA.

Elon Musk‘s brain implant company Neuralink has tapped a top US health regulator responsible for overseeing the company and its competitors, according to a company announcement. US FDA executive David McMullen will lead Neuralink‘s medical affairs division, according to the company’s website, a prominent appointment that calls into question the Trump administration’s promise to end the revolving door of government regulators moving into the private sector.McMullen most recently served as director at the Food and Drug Administration’s Office of Neurological and Physical Medicine Devices, which is responsible for the total lifecycle review of devices such as Neuralink’s brain implant. The move places a top government official inside Musk’s orbit after the billionaire led a government cost-cutting enterprise earlier this year that forced out regulators overseeing Neuralink and other medical device companies. The FDA ended up asking some of those scientists to return.

McMullen holds longtime ties to executives at Neuralink. He previously worked at a neuroscience lab at Duke University along with researchers who went on to the senior ranks at the company.

“This role combines scientific rigor, direct patient impact, and the chance to move the entire field of BCI (brain-computer interfaces) forward,” McMullen said in a statement. Neuralink said in September that 12 people worldwide with severe paralysis have received its brain implants and were using them to control digital and physical tools through thought.

Neuralink began human trials in 2024 on its brain implant after addressing safety concerns raised by the FDA, which had initially rejected its application in 2022. The company earlier faced scrutiny from US regulators over its animal testing program. Neuralink employees previously told Reuters that the company was killing more animals than necessary, including monkeys and pigs, because it was rushing and botching experiments due to time pressures from Musk.

  • Published On Dec 10, 2025 at 11:01 AM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

Get updates on your preferred social platform

Follow us for the latest news, insider access to events and more.


Spread the love

Leave a Reply

Your email address will not be published.

× Free India Logo
Welcome! Free India